Regular Article

British Journal of Cancer (2000) 83, 1473–1479. doi:10.1054/bjoc.2000.1488 www.bjcancer.com
Published online 14 November 2000

Expression of calcium-binding protein S100A2 in breast lesions

D Liu1, P S Rudland1, D R Sibson2, A Platt-Higgins1 and R Barraclough1

  1. 1School of Biological Sciences, University of Liverpool, P.O. Box 147, Liverpool, L69 7ZB, UK
  2. 2Clatterbridge Cancer Research Trust, J.K. Douglas Laboratories, Clatterbridge Hospital, Bebington, Wirral, CH63 4JY, UK

Received 2 May 2000; Revised 31 July 2000; Accepted 14 August 2000.

Top

Abstract

A suppression subtraction cDNA library representing mRNAs expressed at a higher level in a benign breast tumour-derived cell line relative to the malignant MCF-7A cell line contained cDNAs corresponding to mRNAs for plasminogen activator inhibitor I, annexin VIII and the EF-hand protein S100A2. S100A2 protein has previously been shown to be expressed in normal human breast epithelium, but not in human breast carcinoma cell lines. Using a PCR-based assay and in situ hybridization on histological sections of human breast specimens, the mRNA for S100A2 was shown to be present in all benign breast lesions examined as well as in normal epithelium. S100A2 mRNA was detectable in 37% of specimens of carcinoma in situ, but in less than 15% of carcinoma specimens. The results suggest that the loss of S100A2 is associated with the development of malignant cells and is not associated with early tumour development. © 2000 Cancer Research Campaign http://www.bjcancer.com

Keywords:

S100A2, breast cancer, in situ hybridization, carcinoma in situ, suppression subtractive hybridization

Top

References

  1. Altschul S, Gish W, Miller W, Myers E and Lipman D (1990 Basic local alignment search tool. J Mol Biol 215: 403–410 | Article | PubMed | ISI | ChemPort |
  2. Ambartsumian N, Grigorian M, Larsen F, Karlstrom O, Sidenius N, Rygaard J, Georgiev G and Lukanidin E (1996 Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts 1 gene. Oncogene 13: 1621–1630 | PubMed | ISI | ChemPort |
  3. Anandappa S, Winstanley J, Leinster S, Green B, Rudland P and Barraclough R (1994 Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer 69: 772–776 | PubMed | ISI | ChemPort |
  4. Barraclough R, Kimbell R and Rudland PS (1987 Differential control of mRNA levels for Thy-1 antigen and laminin in rat mammary epithelial and myoepithelial-like cells in culture. J Cell Physil 131: 393–401
  5. Briand P, Petersen OW and Van Deurs B (1987 A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically-defined medium. In vitro 23: 181–188
  6. Chang K, Wang G, Freireich E, Daly M, Naylor S, Trujillo J and Stass S (1992 Specific expression of the annexin VIII gene in acute promyeloytic leukaemia. Blood 79: 1802–1810 | PubMed |
  7. Chirgwin JM, Przybyla AE, Macdonald RJ and Rutter WJ (1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299 | Article | PubMed | ISI | ChemPort |
  8. Davies B, Davies M, Gibbs F, Barraclough R and Rudland P (1993 Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein but not with the oncogene EJ ras -1. Oncogene 8: 999–1008 | PubMed | ISI | ChemPort |
  9. Davies M, Rudland P, Robertson L, Parry E, Jolicoeur P and Barraclough R (1996 Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV- neu transgenic mice induces metastasis of mammary tumours. Oncogene 13: 1631–1637 | PubMed | ISI | ChemPort |
  10. Diatchenko L, Lau Y-FC, Campbell A, Chenchik A, Moqadaam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov E and Siebert P (1996 Suppression subtractive hybridisation: a method for generating differentially-regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025–6030 | Article | PubMed | ChemPort |
  11. Donato R (1999 Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1450: 191–231 | Article | PubMed | ISI | ChemPort |
  12. Engel LW and Young NA (1978 Human breast carcinoma cells in continuous culture: a review. Cancer Res 38: 4327–4339 | PubMed | ISI | ChemPort |
  13. Feinberg AP and Vogelstein B (1984 A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137: 266–267 | Article | PubMed | ISI | ChemPort |
  14. Guru SC, Agarwal SK, Manickam P, Olufemi S-E, Crabtree JS, Weisemann JM, Kester M, Kim YS, Emmert-Buck MR, Liotta LA, AM S, Boguski M, Roe BA, Collins FS, Burns AL, Marx SJ and Chandrasekharappa SC (1997 A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res 7: 725–735 | PubMed |
  15. Han JH, Stratowa C and Rutter WJ (1987 Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning. Biochemistry 26: 1617–1625 | Article | PubMed | ISI | ChemPort |
  16. Ke Y, Fernig DG, Wilkinson MC, Winstanley JHR, Smith JA, Rudland PS and Barraclough R (1993 The expression of basic fibroblast growth factor and its receptor in cell lines derived from normal human mammary gland and a benign mammary lesion. J Cell Sci 106: 135–143 | PubMed |
  17. Laborda J (1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19: 3998 | PubMed | ISI | ChemPort |
  18. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K and Sager R (1992 Down-regulation of a member of the S100 gene family in mammary-carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci USA 89: 2504–2508 | PubMed | ChemPort |
  19. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS and Fodstad O (1997 Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 74: 464–469 | Article | PubMed | ISI | ChemPort |
  20. Mandinova A, Atar D, Schafer BW, Spiess M, Aebi U and Heizmann CW (1998 Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J Cell Sci 111: 2043–2054 | PubMed | ISI | ChemPort |
  21. Mueller A, Bachi T, Hochli M, Schäfer BW and Heizmann CW (1999 Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation. Histochem Cell Biol 111: 453–459 | Article | PubMed | ISI | ChemPort |
  22. Pedrocchi M, Schäfer BW, Mueller H, Eppenberger U and Heizmann CW (1994 Expression of Ca2+-binding proteins of the S100 family in malignant human breast-cancer cell-lines and biopsy samples. Int J Cancer 57: 684–690 | PubMed | ISI | ChemPort |
  23. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T and Pelicci PG (1992 A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70: 93–104 | Article | PubMed | ISI | ChemPort |
  24. Platt-Higgins A, Renshaw C, West C, Winstanley J, De Silva Rudland S, Barraclough R and Rudland P (2000 Comparison of the metastasis-inducing protein S100A4 (p9Ka) with other prognostic markers in human breast cancer. Int J Cancer 89: 198–208 | Article | PubMed | ISI | ChemPort |
  25. Rothe M, Pan MG, Henzel WJ, Ayres TM and Goeddel DV (1995 The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243–1252 | Article | PubMed | ISI | ChemPort |
  26. Rudland PS, Ollerhead G and Barraclough R (1989 Isolation of simian virus 40 transformed human mammary epithelial stem cell line that can differentiate to myoepithelial-like cells in culture and. in vivo. Develop Biol 136: 167–180
  27. Rudland P, Platt-Higgins A, Renshaw C, West C, Winstanley J, Robertson L and Barraclough R (2000 Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595–1603 | PubMed | ISI | ChemPort |
  28. Sambrook J, Fritsch EF and Maniatis T (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
  29. Schäfer B and Heizmann C (1996 The S100 family of EF-hand calcium-binding proteins: function and pathology. TIBS 21: 134–140 | PubMed | ChemPort |
  30. Tan MJ, Heizmann CW, Guan KL, Schäfer BW and Sun Y (1999 Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett 445: 265–268 | Article | PubMed | ISI | ChemPort |
  31. Taylor S, Platt-Higgins A, Rudland P, Winstanley J and Barraclough R (1997 Cytoplasmic staining of c- erb B-2 is not associated with the presence of detectable c- erb B-2 mRNA in breast cancer specimens. Int J Cancer 76: 459–463
  32. Wang YX, Rea T, Bian JH, Gray S and Sun Y (1999 Identification of the genes responsive to etoposide-induced apoptosis: application of DNA chip technology. FEBS Lett 445: 269–273 | Article | PubMed | ISI | ChemPort |
  33. Watson DK, McWilliams MJ, Lapis P, Lautenberger JA, Schweinfest CW and Papas TS (1988 Mammalian ets -1 and ets -2 genes encode highly conserved proteins. Proc Natl Acad Sci U.S.A 85: 7862–7866 | PubMed | ChemPort |
  34. Wicki R, Franz C, Scholl FA, Heizmann CW and Schäfer BW (1997 Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site specific hypermethylation. Cell Calcium 22: 243–254 | Article | PubMed | ISI | ChemPort |
  35. Willard HF, Lawrence J, Xing Y, Lafreniere RG, Rupert JL, Hendrich BD and Brown CJ (1992 The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71: 515–529 | Article | PubMed | ISI | ChemPort |
  36. Wun TC and Kretzmer KK (1987 cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell. FEBS Lett 210: 11–16 | Article | PubMed | ISI | ChemPort |